Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Statistics

Total Valuation

TSX:APLI has a market cap or net worth of CAD 1.99 million. The enterprise value is 14.23 million.

Market Cap	1.99M
Enterprise Value	14.23M

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:APLI has 132.37 million shares outstanding. The number of shares has increased by 4.39% in one year.

Current Share Class	132.37M
Shares Outstanding	132.37M
Shares Change (YoY)	+4.39%
Shares Change (QoQ)	+5.85%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	n/a
Float	118.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.62
PB Ratio	-0.12
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.80
EV / Sales	68.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.69

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-291.97%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	39.43%
Weighted Average Cost of Capital (WACC)	7.83%
Revenue Per Employee	29,473
Profits Per Employee	-423,375
Employee Count	7
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:APLI has paid 92,016 in taxes.

Income Tax	92,016
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.07, so TSX:APLI's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	-50.00%
50-Day Moving Average	0.02
200-Day Moving Average	0.02
Relative Strength Index (RSI)	39.11
Average Volume (20 Days)	78,666

Short Selling Information

The latest short interest is 12,229, so 0.01% of the outstanding shares have been sold short.

Short Interest	12,229
Short Previous Month	47,047
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:APLI had revenue of CAD 206,310 and -2.96 million in losses. Loss per share was -0.02.

Revenue	206,310
Gross Profit	206,310
Operating Income	-6.17M
Pretax Income	-2.87M
Net Income	-2.96M
EBITDA	-6.16M
EBIT	-6.17M
Loss Per Share	-0.02

Balance Sheet

The company has 212,754 in cash and 12.46 million in debt, with a net cash position of -12.25 million or -0.09 per share.

Cash & Cash Equivalents	212,754
Total Debt	12.46M
Net Cash	-12.25M
Net Cash Per Share	-0.09
Equity (Book Value)	-16.38M
Book Value Per Share	-0.13
Working Capital	-15.66M

Cash Flow

Operating Cash Flow	-11,332
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-2,990.70%
Pretax Margin	-1,391.89%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:APLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.39%
Shareholder Yield	-4.39%
Earnings Yield	-149.26%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:APLI has an Altman Z-Score of -262.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-262.38
Piotroski F-Score	3